The down-regulation of E-cadherin is common in squamous cell carcinomas (SCC) and is associated with an enhanced ability of invasion and/or metastasis and with a poor prognosis [4]–[6], reflective of its critical role in tumor progression. This evidence concerns the gene CDH1 and squamous cell carcinoma.